(Q28332029)

12 December 2020

On the rational design of renin inhibitors: X-ray studies of aspartic proteinases complexed with transition-state analogues

1 reference

12 December 2020

Renin inhibitors. Improvements in the stability and biological activity of small peptides containing novel Leu-Val replacements

1 reference

12 December 2020

Processing of in vitro-synthesized gag precursor proteins of human immunodeficiency virus (HIV) type 1 by HIV proteinase generated in Escherichia coli.

1 reference

12 December 2020

Retroviral proteases: first glimpses at the anatomy of a processing machine

1 reference

12 December 2020

Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 A resolution

1 reference

12 December 2020

The proteinase inhibitor pepstatin A inhibits formation of reverse transcriptase in H9 cells infected with human immunodeficiency virus 1

1 reference

12 December 2020

A deletion mutation in the 5' part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins.

1 reference

12 December 2020

Inhibition of retroviral protease activity by an aspartyl proteinase inhibitor

1 reference

12 December 2020

1 reference

12 December 2020

Mutational analysis of human immunodeficiency virus type 1 protease suggests functional homology with aspartic proteinases

1 reference

12 December 2020

Inhibition of aspartic proteinases by peptides containing lysine and ornithine side-chain analogues of statine

1 reference

12 December 2020

Effective blocking of HIV-1 proteinase activity by characteristic inhibitors of aspartic proteinases

1 reference

12 December 2020

Active site mutagenesis of the AIDS virus protease and its alleviation by trans complementation

1 reference

12 December 2020

Synthetic and enzyme inhibition studies of pepstatin analogues containing hydroxyethylene and ketomethylene dipeptide isosteres

1 reference

12 December 2020

Synthetic peptides as substrates and inhibitors of human immune deficiency virus-1 protease.

1 reference

12 December 2020

HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus

1 reference

12 December 2020

Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease

1 reference

12 December 2020

Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues

1 reference

12 December 2020

Molecular modeling of the HIV-1 protease and its substrate binding site

1 reference

12 December 2020

Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1

1 reference

12 December 2020

Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitors

1 reference

12 December 2020

Murine leukemia virus maturation: protease region required for conversion from "immature" to "mature" core form and for virus infectivity

1 reference

12 December 2020

HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteins

1 reference

12 December 2020

Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease

1 reference

12 December 2020

Active human immunodeficiency virus protease is required for viral infectivity

1 reference

12 December 2020

An assay for quantifying infectious HIV particles

1 reference

12 December 2020

Dimensions Publication ID

Identifiers

DOI

10.1007/BF01310746

0 references

1037223099

0 references

Fatcat ID

release_cic65pkxurbb5ibx4kmprlhwwy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cic65pkxurbb5ibx4kmprlhwwy

24 November 2022